These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 34296676)

  • 1. Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
    Kissling E; Hooiveld M; Sandonis Martín V; Martínez-Baz I; William N; Vilcu AM; Mazagatos C; Domegan L; de Lusignan S; Meijer A; Machado A; Brytting M; Casado I; Murray JK; Belhillil S; Larrauri A; O'Donnell J; Tsang R; de Lange M; Rodrigues AP; Riess M; Castilla J; Hamilton M; Falchi A; Pozo F; Dunford L; Cogdale J; Jansen T; Guiomar R; Enkirch T; Burgui C; Sigerson D; Blanchon T; Martínez Ochoa EM; Connell J; Ellis J; van Gageldonk-Lafeber R; Kislaya I; Rose AM; Valenciano M; ;
    Euro Surveill; 2021 Jul; 26(29):. PubMed ID: 34296676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
    Kissling E; Hooiveld M; Martínez-Baz I; Mazagatos C; William N; Vilcu AM; Kooijman MN; Ilić M; Domegan L; Machado A; de Lusignan S; Lazar M; Meijer A; Brytting M; Casado I; Larrauri A; Murray JK; Behillil S; de Gier B; Mlinarić I; O'Donnell J; Rodrigues AP; Tsang R; Timnea O; de Lange M; Riess M; Castilla J; Pozo F; Hamilton M; Falchi A; Knol MJ; Kurečić Filipović S; Dunford L; Guiomar R; Cogdale J; Cherciu C; Jansen T; Enkirch T; Basile L; Connell J; Gomez V; Sandonis Martín V; Bacci S; Rose AM; Pastore Celentano L; Valenciano M; ;
    Euro Surveill; 2022 May; 27(21):. PubMed ID: 35620997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
    Lanièce Delaunay C; Martínez-Baz I; Sève N; Domegan L; Mazagatos C; Buda S; Meijer A; Kislaya I; Pascu C; Carnahan A; Oroszi B; Ilić M; Maurel M; Melo A; Sandonis Martín V; Trobajo-Sanmartín C; Enouf V; McKenna A; Pérez-Gimeno G; Goerlitz L; de Lange M; Rodrigues AP; Lazar M; Latorre-Margalef N; Túri G; Castilla J; Falchi A; Bennett C; Gallardo V; Dürrwald R; Eggink D; Guiomar R; Popescu R; Riess M; Horváth JK; Casado I; García MDC; Hooiveld M; Machado A; Bacci S; Kaczmarek M; Kissling E;
    Euro Surveill; 2024 Mar; 29(13):. PubMed ID: 38551095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024.
    Laniece Delaunay C; Melo A; Maurel M; Mazagatos C; Goerlitz L; O'Donnell J; Oroszi B; Sève N; Rodrigues AP; Martínez-Baz I; Meijer A; Mlinarić I; Latorre-Margalef N; Lazăr M; Pérez-Gimeno G; Dürrwald R; Bennett C; Túri G; Rameix-Welti MA; Guiomar R; Castilla J; Hooiveld M; Kurečić Filipović S; Samuelsson Hagey T; Dijkstra F; Borges V; Ramos Marín V; Bacci S; Kaczmarek M; Kissling E;
    Vaccine; 2024 Jul; 42(19):3931-3937. PubMed ID: 38839521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization.
    Chodick G; Tene L; Patalon T; Gazit S; Ben Tov A; Cohen D; Muhsen K
    JAMA Netw Open; 2021 Jun; 4(6):e2115985. PubMed ID: 34097044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
    Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS
    Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children.
    Gujar N; Tambe M; Parande M; Salunke N; Jagdale G; Anderson SG; Dharmadhikari A; Lakhkar A; Kulkarni PS
    Hum Vaccin Immunother; 2021 Oct; 17(10):3316-3321. PubMed ID: 34128766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020.
    Kissling E; Hooiveld M; Brytting M; Vilcu AM; de Lange M; Martínez-Baz I; Sigerson D; Enkirch T; Belhillil S; Meijer A; Castilla J; William N; Carnahan A; Falchi A; Hendriksen J; Casado I; Murray J; Enouf V; Dijkstra F; Marques DFP; Valenciano M
    Influenza Other Respir Viruses; 2021 Jul; 15(4):429-438. PubMed ID: 33481344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prioritizing the First Doses of SARS-CoV-2 Vaccine to Save the Elderly: The Case Study of Italy.
    Pontrelli G; Cimini G; Roversi M; Gabrielli A; Salina G; Bernardi S; Rocchi F; Simonetti A; Giaquinto C; Rossi P; Sylos Labini F
    Front Public Health; 2021; 9():684760. PubMed ID: 34336771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.
    Teran RA; Walblay KA; Shane EL; Xydis S; Gretsch S; Gagner A; Samala U; Choi H; Zelinski C; Black SR
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):632-638. PubMed ID: 33914721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill-An interim analysis of a nationwide cohort study.
    Baum U; Poukka E; Palmu AA; Salo H; Lehtonen TO; Leino T
    PLoS One; 2021; 16(11):e0258704. PubMed ID: 34793476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021.
    Harder T; Koch J; Vygen-Bonnet S; Külper-Schiek W; Pilic A; Reda S; Scholz S; Wichmann O
    Euro Surveill; 2021 Jul; 26(28):. PubMed ID: 34269175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.
    de Gier B; Andeweg S; Backer JA; ; Hahné SJ; van den Hof S; de Melker HE; Knol MJ;
    Euro Surveill; 2021 Nov; 26(44):. PubMed ID: 34738514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021.
    Martínez-Baz I; Miqueleiz A; Casado I; Navascués A; Trobajo-Sanmartín C; Burgui C; Guevara M; Ezpeleta C; Castilla J;
    Euro Surveill; 2021 May; 26(21):. PubMed ID: 34047271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study.
    Luong Ngyen LB; Bauer R; Lesieur Z; Galtier F; Duval X; Vanhems P; Lainé F; Tattevin P; Durier C; Launay O;
    Infect Dis Now; 2022 Feb; 52(1):40-43. PubMed ID: 34920180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine effectiveness among the staff of the Bologna Health Trust, Italy, December 2020-April 2021.
    Giansante C; Stivanello E; Perlangeli V; Ferretti F; Marzaroli P; Musti MA; Pizzi L; Resi D; Saraceni S; Pandolfi P
    Acta Biomed; 2021 Sep; 92(4):e2021270. PubMed ID: 34487060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
    Stuurman AL; Biccler J; Carmona A; Descamps A; Díez-Domingo J; Muñoz Quiles C; Nohynek H; Rizzo C; Riera-Montes M;
    Vaccine; 2021 Jun; 39(29):3964-3973. PubMed ID: 34092427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles and new perspectives in the vaccination against SARS-CoV-2 virus.
    Smetanová J; Střížová Z; Bartůňková J; Milota T
    Cas Lek Cesk; 2020; 159(7-8):298-302. PubMed ID: 33445936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.
    de Gier B; Andeweg S; Joosten R; Ter Schegget R; Smorenburg N; van de Kassteele J; ; Hahné SJ; van den Hof S; de Melker HE; Knol MJ;
    Euro Surveill; 2021 Aug; 26(31):. PubMed ID: 34355689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.